JPH0461663B2 - - Google Patents
Info
- Publication number
- JPH0461663B2 JPH0461663B2 JP60091613A JP9161385A JPH0461663B2 JP H0461663 B2 JPH0461663 B2 JP H0461663B2 JP 60091613 A JP60091613 A JP 60091613A JP 9161385 A JP9161385 A JP 9161385A JP H0461663 B2 JPH0461663 B2 JP H0461663B2
- Authority
- JP
- Japan
- Prior art keywords
- catheter
- obturator
- blood
- immobilized
- intravascular
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 230000003480 fibrinolytic effect Effects 0.000 claims description 13
- 239000013543 active substance Substances 0.000 claims description 9
- 239000003527 fibrinolytic agent Substances 0.000 claims description 8
- 239000000126 substance Substances 0.000 claims description 8
- 108090000435 Urokinase-type plasminogen activator Proteins 0.000 claims description 6
- 102000003990 Urokinase-type plasminogen activator Human genes 0.000 claims description 6
- 239000003146 anticoagulant agent Substances 0.000 claims description 6
- 229960005356 urokinase Drugs 0.000 claims description 6
- 230000002785 anti-thrombosis Effects 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 2
- 210000004369 blood Anatomy 0.000 description 11
- 239000008280 blood Substances 0.000 description 11
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 8
- 239000002504 physiological saline solution Substances 0.000 description 7
- 102000009123 Fibrin Human genes 0.000 description 6
- 108010073385 Fibrin Proteins 0.000 description 6
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 6
- 229950003499 fibrin Drugs 0.000 description 6
- 208000007536 Thrombosis Diseases 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 229940127219 anticoagulant drug Drugs 0.000 description 4
- 230000023555 blood coagulation Effects 0.000 description 4
- 229920001577 copolymer Polymers 0.000 description 4
- 238000001802 infusion Methods 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 108010023197 Streptokinase Proteins 0.000 description 3
- 229920003023 plastic Polymers 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 229920002635 polyurethane Polymers 0.000 description 3
- 239000004814 polyurethane Substances 0.000 description 3
- 229960005202 streptokinase Drugs 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- 108090000373 Tissue Plasminogen Activator Proteins 0.000 description 2
- 102000003978 Tissue Plasminogen Activator Human genes 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- -1 polyethylene Polymers 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 229920000915 polyvinyl chloride Polymers 0.000 description 2
- 239000004800 polyvinyl chloride Substances 0.000 description 2
- 229960000187 tissue plasminogen activator Drugs 0.000 description 2
- 229920000936 Agarose Polymers 0.000 description 1
- 108010073975 Brinolase Proteins 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 108010088842 Fibrinolysin Proteins 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 244000043261 Hevea brasiliensis Species 0.000 description 1
- 108010093096 Immobilized Enzymes Proteins 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 102000013566 Plasminogen Human genes 0.000 description 1
- 108010051456 Plasminogen Proteins 0.000 description 1
- 229920002845 Poly(methacrylic acid) Polymers 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 108090000190 Thrombin Proteins 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 229940086617 aspergillus flavus var. oryzae protease Drugs 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 230000001112 coagulating effect Effects 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000020764 fibrinolysis Effects 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 229940106780 human fibrinogen Drugs 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 229920003052 natural elastomer Polymers 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 229920001194 natural rubber Polymers 0.000 description 1
- 229940012957 plasmin Drugs 0.000 description 1
- 229920001308 poly(aminoacid) Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229920002050 silicone resin Polymers 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229960004072 thrombin Drugs 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 210000001631 vena cava inferior Anatomy 0.000 description 1
Landscapes
- Media Introduction/Drainage Providing Device (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP60091613A JPS61249478A (ja) | 1985-04-27 | 1985-04-27 | 血管内留置カテ−テル用抗血栓性オブチユレ−タ− |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP60091613A JPS61249478A (ja) | 1985-04-27 | 1985-04-27 | 血管内留置カテ−テル用抗血栓性オブチユレ−タ− |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS61249478A JPS61249478A (ja) | 1986-11-06 |
| JPH0461663B2 true JPH0461663B2 (enExample) | 1992-10-01 |
Family
ID=14031417
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP60091613A Granted JPS61249478A (ja) | 1985-04-27 | 1985-04-27 | 血管内留置カテ−テル用抗血栓性オブチユレ−タ− |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS61249478A (enExample) |
-
1985
- 1985-04-27 JP JP60091613A patent/JPS61249478A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS61249478A (ja) | 1986-11-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1338756C (en) | Hirudin-coated biocompatible substance | |
| US20080095760A1 (en) | Methods of treating stroke | |
| US4305926A (en) | Immobilization of Streptokinase | |
| JPH0456591B2 (enExample) | ||
| EP0620738A1 (en) | Fibrinolysis and fibrinogenolysis treatment with plasmin | |
| WO1993007893A1 (en) | Fibrinolysis and fibrinogenolysis treatment with plasmin | |
| AU3988289A (en) | Biocompatible substance with thromboresistance | |
| JPH0461663B2 (enExample) | ||
| Plate et al. | On the mechanism of enhanced thromboresistance of polymeric materials in the presence of heparin | |
| US6455269B1 (en) | Method for localized administration of fibrinolytic metalloproteinases | |
| JP3398415B2 (ja) | 抗血栓性カテーテル | |
| JPH04285561A (ja) | 医療用材料の滅菌方法および医療用器具の製造方法 | |
| JPH09173461A (ja) | 血管内留置カテーテル用オブチュレーター | |
| JP4252123B2 (ja) | 固定化線維素溶解活性酵素の活性安定化法 | |
| JPH10234857A (ja) | 血管内留置カテーテル用オブチュレーター | |
| JP3043096B2 (ja) | 抗血栓性医用材料、医用器具および抗血栓性医用材料の製造方法 | |
| JPH04146763A (ja) | 医療用基材へのゲル状物質付着方法 | |
| JPH11299880A (ja) | カテーテル | |
| JPS62217970A (ja) | 抗凝血性医用材料及びその製造方法 | |
| JP2004008628A (ja) | 医療用具の製造方法 | |
| JPH0414032B2 (enExample) | ||
| JPH0638852B2 (ja) | 抗血栓性材料及びその製法 | |
| RU2388495C1 (ru) | Способ получения тромборезистентных полимерных материалов | |
| JPH04146766A (ja) | 抗血栓性医用材料および医用器具 | |
| Takaseya et al. | Acute Swine Model for Assessing Biocompatibility of Biomedical Interface Materials |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EXPY | Cancellation because of completion of term |